These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 33097833)

  • 1. Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells.
    Wang K; Zhang Z; Tsai HI; Liu Y; Gao J; Wang M; Song L; Cao X; Xu Z; Chen H; Gong A; Wang D; Cheng F; Zhu H
    Cell Death Differ; 2021 Apr; 28(4):1222-1236. PubMed ID: 33097833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
    Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
    Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Course of Changes in Sorafenib-Treated Hepatocellular Carcinoma Cells Suggests Involvement of Phospho-Regulated Signaling in Ferroptosis Induction.
    Werth EG; Rajbhandari P; Stockwell BR; Brown LM
    Proteomics; 2020 May; 20(10):e2000006. PubMed ID: 32336023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
    Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
    J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.
    Li Q; Yuan H; Zhao G; Ou D; Zhang J; Li L; Li S; Feng T; Gu R; Kou Q; Wang Q; Li S; Wang G; Zhao M; Yu H; Qu J; Lin P; Li K
    Biochem Pharmacol; 2024 Jul; 225():116251. PubMed ID: 38701867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.
    Li J; Li Y; Wang D; Liao R; Wu Z
    J Exp Clin Cancer Res; 2024 May; 43(1):143. PubMed ID: 38745179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
    Ji J; Cheng Z; Zhang J; Wu J; Xu X; Guo C; Feng J
    J Cell Mol Med; 2024 Apr; 28(8):e18335. PubMed ID: 38652216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
    Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
    Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
    Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma.
    Chen Y; Li L; Lan J; Cui Y; Rao X; Zhao J; Xing T; Ju G; Song G; Lou J; Liang J
    Mol Cancer; 2022 Jan; 21(1):11. PubMed ID: 34983546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase.
    Xu FL; Wu XH; Chen C; Wang K; Huang LY; Xia J; Liu Y; Shan XF; Tang N
    Cell Death Dis; 2023 Jan; 14(1):22. PubMed ID: 36635256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
    Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
    Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma.
    Hu X; Zhang P; Li S; Zhang J; Wang D; Wang Z; Zhu L; Wang L
    J Transl Med; 2024 Jun; 22(1):593. PubMed ID: 38918793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X
    Song X; Zhu S; Chen P; Hou W; Wen Q; Liu J; Xie Y; Liu J; Klionsky DJ; Kroemer G; Lotze MT; Zeh HJ; Kang R; Tang D
    Curr Biol; 2018 Aug; 28(15):2388-2399.e5. PubMed ID: 30057310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development.
    Kang ZR; Jiang S; Han JX; Gao Y; Xie Y; Chen J; Liu Q; Yu J; Zhao X; Hong J; Chen H; Chen YX; Chen H; Fang JY
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166941. PubMed ID: 37926361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
    Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z
    Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3.
    Liu W; Deng J; Tao XJ; Peng Y; Chen XD; Qu XC; Deng HW; Tan LJ
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39155877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.